DPW
RVMD icon

DiNuzzo Private Wealth’s Revolution Medicines RVMD Stock Holding History

DiNuzzo Private Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5K Sell
8
-7
-47% -$1.02K ﹤0.01% 775
2026
Q1 		$1.46K Hold
15
– – ﹤0.01% 756
2025
Q4 		$1.2K Buy
15
+9
+150% +$590 ﹤0.01% 825
2025
Q3 		$228 Buy
6
+3
+100% +$117 ﹤0.01% 1250
2025
Q2 		$111 Hold
3
– – ﹤0.01% 1295
2025
Q1 		$107 Hold
3
– – ﹤0.01% 1295
2024
Q4 		$132 Hold
3
– – ﹤0.01% 1318
2024
Q3 		$137 Hold
3
– – ﹤0.01% 1340
2024
Q2 		$117 Hold
3
– – ﹤0.01% 1330
2024
Q1 		$97 Hold
3
– – ﹤0.01% 1292
2023
Q4 		$87 Buy
+3
New +$72 ﹤0.01% 1334

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DiNuzzo Private Wealth's RVMD Position: Q2 2026 in Review

DiNuzzo Private Wealth reduced its Revolution Medicines (RVMD) stake by 47% in Q2 2026, selling an estimated $1.02K and leaving 8 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #775.

DiNuzzo Private Wealth first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • DiNuzzo Private Wealth held 8 shares of Revolution Medicines worth $1.5K as of Q2 2026.
  • DiNuzzo Private Wealth sold 7 Revolution Medicines shares in Q2 2026, an estimated $1.02K.
  • Revolution Medicines made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #775 holding.
  • DiNuzzo Private Wealth first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.